NRCAM: A Potential Drug Target and Biomarker for Neuronal Cell Adhesion

Target Name: NRCAM

NCBI ID: G4897

NRCAM

NRCAM: A Potential Drug Target and Biomarker for Neuronal Cell Adhesion

Introduction

Neuronal cell adhesion plays a crucial role in the development and maintenance of neural tissues, and its regulation is tightly controlled by a complex network of proteins. One of the key proteins involved in this process is the neurotransmitter-gated chloride channel, known as NRCAM ( Neuronal Cell Adhesion Molecule, transcript variant 1). This protein is expressed in high levels in brain and spinal cord tissues and is involved in the regulation of neuronal excitability and synaptic plasticity. As a result, NRCAM has been identified as a potential drug target and biomarker for a variety of neurological and psychiatric disorders.

During the past decade, significant research has been conducted to understand the mechanisms underlying NRCAM function. This has led to the identification of several potential drug targets and biomarkers that may be involved in its regulation. In this article, we will review the current understanding of NRCAM and its potential as a drug target and biomarker.

NRCAM: Structure and Function

NRCAM is a member of the immunoglobulin superfamily and is expressed in a variety of tissues, including brain, spinal cord, and muscle. It is characterized by a long extracellular domain that contains a putative transmembrane region and several short cytoplasmic domains. The cytoplasmic domain includes a unique feature known as a N-terminal terminal ion channel that is responsible for the regulation of neuronal excitability and synaptic plasticity.

The NRCAM channel is a type of chloride channel that is expressed in high levels in brain and spinal cord tissues. It is involved in the regulation of neuronal excitability and synaptic plasticity and is thought to play a key role in the development and maintenance of neural tissues..

NRCAM has been shown to regulate a variety of physiological processes in the brain and nervous system, including neuronal excitability, synaptic plasticity, and neurotransmitter release. It has also been implicated in a variety of neurological and psychiatric disorders, including epilepsy, schizophrenia, and mood disorders.

Potential Drug Targets

NRCAM is a protein that has been identified as a potential drug target for a variety of neurological and psychiatric disorders. Several studies have shown that modulation of NRCAM function is involved in the development and progression of these disorders.

One potential drug target for NRCAM is the use of small molecules that can modulate the activity of the NRCAM channel. These small molecules include a variety of compounds, including agonists for the NRCAM channel, such as amantidine and benzodiazepines, as well as antagonists, such as gabapentin and baclofen.

Another potential drug target for NRCAM is the use of antibodies that can specifically modulate the activity of the NRCAM channel. These antibodies include monoclonal antibodies (MCABs) that can specifically bind to the NRCAM channel and modulate its function.

Biomarkers

NRCAM has also been identified as a potential biomarker for a variety of neurological and psychiatric disorders. Several studies have shown that the expression of NRCAM is altered in these disorders and that modulation of NRCAM function may be involved in the development and progression of these disorders.

One potential biomarker for NRCAM-related disorders is the use of enzyme assays, such as protein kinase assays, that can measure the activity of the NRCAM channel. These assays can be used to detect changes in NRCAM function that are associated with the development and progression of disorders.

Another potential biomarker for NRCAM-related disorders is the use of animal models of nervous system disorders, such as the use of mice or rats with genetic modifications in

Protein Name: Neuronal Cell Adhesion Molecule

Functions: Cell adhesion protein that is required for normal responses to cell-cell contacts in brain and in the peripheral nervous system. Plays a role in neurite outgrowth in response to contactin binding. Plays a role in mediating cell-cell contacts between Schwann cells and axons. Plays a role in the formation and maintenance of the nodes of Ranvier on myelinated axons. Nodes of Ranvier contain clustered sodium channels that are crucial for the saltatory propagation of action potentials along myelinated axons. During development, nodes of Ranvier are formed by the fusion of two heminodes. Required for normal clustering of sodium channels at heminodes; not required for the formation of mature nodes with normal sodium channel clusters. Required, together with GLDN, for maintaining NFASC and sodium channel clusters at mature nodes of Ranvier

The "NRCAM Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NRCAM comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets